Cargando…

Does the world need germline editing for β-thalassemia?

Detalles Bibliográficos
Autor principal:	Kulozik, Andreas E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152967/ https://www.ncbi.nlm.nih.gov/pubmed/34706499 http://dx.doi.org/10.3324/haematol.2021.279998

Ejemplares similares

The therapeutic potential of genome editing for β-thalassemia
por: Glaser, Astrid, et al.
Publicado: (2015)

Does the World Need Plant Medicines?
por: Adams, James David
Publicado: (2018)

Does the World Still Need New Covid-19 Vaccines?
por: Nohynek, Hanna, et al.
Publicado: (2022)

Technical Problems and Ethical Concerns Regarding Gene Editing in Human Germlines and Embryos
por: Sadeghi, Mohammad Reza
Publicado: (2023)

Does the “world” still need to keep live samples of the smallpox virus?
por: Muula, Adamson S
Publicado: (2022)

Luspatercept for transfusion-dependent β-thalassemia: time to get real
por: Musallam, Khaled M., et al.
Publicado: (2023)

Does the world need a scientific society for research on how to improve healthcare?
por: Wensing, Michel, et al.
Publicado: (2012)

Is RBC discrimination index suitable for differentiating between α- and β- thalassemias?
por: Gorakshakar, Ajit C., et al.
Publicado: (2011)

β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
por: Karimi, Mehran, et al.
Publicado: (2012)

Does human germline genome editing violate human dignity? An African perspective
por: Shozi, Bonginkosi
Publicado: (2021)

The Ethics of Germline Gene Editing
por: Gyngell, Christopher, et al.
Publicado: (2016)

The need to perform α‐thalassemia genetic testing in Italian patients with β‐thalassemia trait: A case report
por: Santoro, Graziano, et al.
Publicado: (2022)

Prevalence of malocclusion and assessment of treatment needs in β-thalassemia major children
por: Gupta, Deepak Kumar, et al.
Publicado: (2016)

Germline gene editing and the precautionary principle
por: Koplin, Julian J., et al.
Publicado: (2019)

The Integrated Care Workforce: What does it Need? Who does it Take?
por: Stein, K. V., et al.
Publicado: (2023)

Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
por: Mettananda, Sachith, et al.
Publicado: (2017)

Serum Lipids in Turkish Patients with β-Thalassemia Major and β-Thalassemia Minor
por: Işık Balcı, Yasemin, et al.
Publicado: (2016)

Vulnerability and the Ethics of Human Germline Genome Editing
por: Labude, Markus K., et al.
Publicado: (2022)

Responsible Translational Pathways for Germline Gene Editing?
por: Cwik, Bryan
Publicado: (2020)

Does Europe need paediatric virologists?
por: Mammas, Ioannis N., et al.
Publicado: (2018)

The need for data in the world’s most violent country
por: B-Lajoie, Marie-Renée, et al.
Publicado: (2014)

Therapeutic genome editing of an aberrant splice site in β-thalassemia by CRISPR/Cas9 with multiple sgRNAs
por: Yang, Fei, et al.
Publicado: (2023)

Does crystallography need a new name?
por: Argyriou, Dimitri
Publicado: (2017)

Does Chicago Need Two Medical Societies?
Publicado: (1878)

Recent advances in β-thalassemias
por: Cao, Antonio, et al.
Publicado: (2011)

Ineffective Erythropoiesis in β-Thalassemia
por: Ribeil, Jean-Antoine, et al.
Publicado: (2013)

Molecular Diagnostics of β-Thalassemia
por: Atanasovska, B, et al.
Publicado: (2012)

β-Thalassemia Intermedia: Interaction of α-Globin Gene Triplication With β-thalassemia Heterozygous in Spain
por: Ropero, Paloma, et al.
Publicado: (2022)

Echocardiografic abnormalities in patients with sickle cell/β-thalassemia do not depend on the β-thalassemia phenotype
por: Benites, Bruno Deltreggia, et al.
Publicado: (2019)

Responsible governance of human germline genome editing in China
por: Peng, Yaojin, et al.
Publicado: (2022)

Human germline gene editing. Recommendations of ESHG and ESHRE(†)(‡)
por: de Wert, Guido, et al.
Publicado: (2018)

Glioma: interaction of acquired and germline genetics
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2021)

Germline genome editing versus preimplantation genetic diagnosis: Is there a case in favour of germline interventions?
por: Ranisch, Robert
Publicado: (2019)

Susceptibility of β-Thalassemia Heterozygotes to COVID-19
por: Sotiriou, Sotirios, et al.
Publicado: (2021)

Thalassemia care in Nepal: In dire need of improvement
por: Sharma Poudyal, Bishesh, et al.
Publicado: (2023)

Correction of RNA splicing defect in β(654)-thalassemia mice using CRISPR/Cas9 gene-editing technology
por: Lu, Dan, et al.
Publicado: (2021)

Real‐World Data Related to the Topics of 6th Edition of Gastric Cancer Treatment Guidelines
por: Shimada, Hideaki
Publicado: (2021)

Why Does Kazakhstan Need New Scientific Journals?
por: Adambekov, Shalkar, et al.
Publicado: (2014)

β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint
por: De Sanctis, Vincenzo, et al.
Publicado: (2017)

Analysis of Common Beta-Thalassemia (β-Thalassemia) Mutations in East Java, Indonesia
por: Hernaningsih, Yetti, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_actiheaeg5ht3ol8bua2bdlep1